Health Care Sector Update for 07/03/2019: UMRX, MOR, GSK, RDHL, JNJ, PFE, ABT, MRK, AMGN
Top Health Care Stocks:
Most health care majors were mixed in pre-bell trading Wednesday.
Early movers include:
(-) Unum Therapeutics ( UMRX ), which was slumping by more than 16% after the company said the US Food and Drug Administration placed a hold on its phase 1 trial of Unum’s ACTR087 in combination with rituximab to treat lymphoma after a patient in the study suffered an infection and respiratory distress.
(+) MorphoSys AG ( MOR ) was flat after GlaxoSmithKline ( GSK ) said it has commenced a phase 3 clinical development program with otilimab (formerly MOR103/GSK3196165) in rheumatoid arthritis. According to MorphoSys, dosing of the first patient will trigger a milestone payment of EUR22 million ($24 million).
(+) Redhill Biopharma ( RDHL ) was gaining more than 4% in value after reporting that that the US Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for Talicia (RHB-105)1 for H. pylori infection.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.